AU3542697A - Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate - Google Patents

Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate

Info

Publication number
AU3542697A
AU3542697A AU35426/97A AU3542697A AU3542697A AU 3542697 A AU3542697 A AU 3542697A AU 35426/97 A AU35426/97 A AU 35426/97A AU 3542697 A AU3542697 A AU 3542697A AU 3542697 A AU3542697 A AU 3542697A
Authority
AU
Australia
Prior art keywords
carbazolyl
oxy
active ingredient
pharmaceutical formulations
topical application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35426/97A
Other languages
English (en)
Inventor
Hans-Georg Opitz
Gisbert Sponer
Heinrich Woog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19628335A external-priority patent/DE19628335A1/de
Priority claimed from DE1997124752 external-priority patent/DE19724752A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU3542697A publication Critical patent/AU3542697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
AU35426/97A 1996-07-13 1997-07-08 Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate Abandoned AU3542697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19628335A DE19628335A1 (de) 1996-07-13 1996-07-13 Verwendung von Carbazolyl-(4)-oxy-propanolamin-Derivaten zur topischen Behandlung von peripheren Durchblutungsstörungen
DE19628335 1996-07-13
DE19724752 1997-04-24
DE1997124752 DE19724752A1 (de) 1997-04-24 1997-04-24 Verwendung von Carbazolyl-(4)-oxy-propanolamin-Derivaten zur topischen Behandlung von Entzündungen und Wunden der Haut
PCT/EP1997/003602 WO1998002157A1 (fr) 1996-07-13 1997-07-08 Formulations pharmaceutiques pour utilisation topique contenant comme principe actif un derive de carbazolyl-(4)-oxy-propanolamine

Publications (1)

Publication Number Publication Date
AU3542697A true AU3542697A (en) 1998-02-09

Family

ID=26027495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35426/97A Abandoned AU3542697A (en) 1996-07-13 1997-07-08 Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate

Country Status (3)

Country Link
EP (1) EP0910374A1 (fr)
AU (1) AU3542697A (fr)
WO (1) WO1998002157A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69938837D1 (de) 1998-11-04 2008-07-10 Serono Genetics Inst Sa Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
CN103254114A (zh) 2002-06-27 2013-08-21 史密斯克莱.比奇曼（科克）有限公司 卡维地洛磷酸盐和/或其溶剂合物相应的组合物和/或治疗方法
JP2005533822A (ja) 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド 臭化水素酸カルベジロール
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2337154C2 (de) * 1973-07-18 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue Carbazolderivate
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
ZA938897B (en) * 1992-12-01 1994-08-01 Smithkline Beecham Corp Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds

Also Published As

Publication number Publication date
WO1998002157A1 (fr) 1998-01-22
EP0910374A1 (fr) 1999-04-28

Similar Documents

Publication Publication Date Title
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
EP0727217A3 (fr) Compositions pharmaceutiques et cosmétiques contenant ellagitannin du type god comme principe actif
AU2595697A (en) Compounds and compositions for delivering active agents
AUPM969994A0 (en) Equine anthelmintic formulations
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
HUP0000568A3 (en) Gel formulations for topical drug delivery containing 4-amino-2-ethoxymethyl-alpha, alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
AU7572196A (en) Pharmaceutical formulations
AU4256996A (en) Parasiticide formulations suitable for dermal application
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
HUP9900617A3 (en) Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds
HU9802795D0 (en) Pharmaceutical compositions containing more active components
AU1689999A (en) Medicinal composition for percutaneous administration
EP1090912A4 (fr) Derives d'acides amines et medicaments contenant lesdits derives en tant que principe actif
NZ318391A (en) Fungicidal compositions comprising fenazaquine as an active substance
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU3261297A (en) New insecticide formulations
AU4232997A (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations
AU1354495A (en) Formulations for orally administered pharmaceutical agents
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
AU3542697A (en) Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate